Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention.

Andreotti M, Guidotti G, Galluzzo CM, Mancinelli S, Germano P, Pirillo MF, Marazzi MC, Vella S, Palombi L, Giuliano M.

AIDS. 2007 Nov 12;21(17):2360-2. No abstract available.

PMID:
18090293
2.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
3.

Prevention of breast milk transmission of HIV: the time is now.

Mofenson LM.

J Acquir Immune Defic Syndr. 2009 Nov 1;52(3):305-8. doi: 10.1097/QAI.0b013e3181bbfe14. No abstract available.

PMID:
19726999
4.

Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.

Simpore J, Pietra V, Pignatelli S, Karou D, Nadembega WM, Ilboudo D, Ceccherini-Silberstein F, Ghilat-Avoid-Belem WN, Bellocchi MC, Saleri N, Sanou MJ, Ouedraogo CM, Nikiema JB, Colizzi V, Perno CP, Castelli F, Musumeci S.

J Med Virol. 2007 Jul;79(7):873-9.

PMID:
17516517
5.

Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk.

Shapiro RL, Ndung'u T, Lockman S, Smeaton LM, Thior I, Wester C, Stevens L, Sebetso G, Gaseitsiwe S, Peter T, Essex M.

J Infect Dis. 2005 Sep 1;192(5):713-9. Epub 2005 Jul 27.

PMID:
16088820
6.

Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.

Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, Marazzi MC, Mancini MG, Cusato M, Germano P, Loureiro S, Ceffa S, Regazzi M, Vella S, Palombi L.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):286-91.

PMID:
17146372
7.
8.

Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.

Clin Infect Dis. 2009 Jul 15;49(2):299-305. doi: 10.1086/599612.

PMID:
19522656
9.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L; ANRS French Perinatal Cohort.

AIDS. 2008 Jan 11;22(2):289-99.

PMID:
18097232
10.

Pasteurization of milk from an HIV-infected woman.

Verd S.

Infect Dis Obstet Gynecol. 2006;2006:35482. No abstract available.

11.

Use of antiretroviral drugs to prevent HIV-1 transmission through breast-feeding: from animal studies to randomized clinical trials.

Gaillard P, Fowler MG, Dabis F, Coovadia H, Van Der Horst C, Van Rompay K, Ruff A, Taha T, Thomas T, De Vincenzi I, Newell ML; Ghent IAS Working Group on HIV in Women and Children.

J Acquir Immune Defic Syndr. 2004 Feb 1;35(2):178-87. Review.

PMID:
14722452
12.

Prevention of mother-to-child HIV transmission: similar access for sub-Sahara African immigrants and for French women?

Jasseron C, Mandelbrot L, Tubiana R, Teglas JP, Faye A, Dollfus C, Le Chenadec J, Rouzioux C, Blanche S, Warszawski J; ANRS French Perinatal Cohort.

AIDS. 2008 Jul 31;22(12):1503-11. doi: 10.1097/QAD.0b013e3283065b8c.

PMID:
18614874
13.

Use of antiretroviral drugs to prevent sexual transmission of HIV.

Cohen MS, Hosseinipour M, Kashuba A, Butera S.

Curr Clin Top Infect Dis. 2002;22:214-51. Review. No abstract available.

PMID:
12520656
14.

The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa.

Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R; PharmAccess African Studies to Evaluate Resistance Programme.

Antivir Ther. 2008;13(5):625-39. Review. Erratum in: Antivir Ther. 2008;13(8):1129.

PMID:
18771046
15.

Effect of perinatal zidovudine prophylaxis on the evolution of cell-free HIV-1 RNA in breast milk and on postnatal transmission.

Manigart O, Crepin M, Leroy V, Meda N, Valea D, Janoff EN, Rouet F, Dequae-Merchadoux L, Dabis F, Rouzioux C, Van de Perre P; Diminution de la Transmission Mere-Enfant Study Group.

J Infect Dis. 2004 Oct 15;190(8):1422-8. Epub 2004 Sep 9.

PMID:
15378434
16.

[Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].

Boer K, Nellen JF, Kreyenbroek ME, Godfried MH.

Ned Tijdschr Geneeskd. 2009;153:B410. Review. Dutch.

PMID:
19785876
17.

HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission.

Lehman DA, Chung MH, John-Stewart GC, Richardson BA, Kiarie J, Kinuthia J, Overbaugh J.

AIDS. 2008 Jul 31;22(12):1475-85. doi: 10.1097/QAD.0b013e328302cc11.

18.

Advances in antiretroviral therapy.

Sobieszczyk ME, Talley AK, Wilkin T, Hammer SM.

Top HIV Med. 2005 Mar-Apr;13(1):24-44.

19.

Long-term reduction of HIV transmission from mother to breastfed child by antiretroviral agents: are more drugs better than less?

Van de Perre P, Manigart O, Meda N.

AIDS. 2001 Mar 30;15(5):658-9. No abstract available.

PMID:
11317009
20.

Combination antiretroviral therapy in african nursing mothers and drug exposure in their infants: new pharmacokinetic and virologic findings.

Bulterys M, Weidle PJ, Abrams EJ, Fowler MG.

J Infect Dis. 2005 Sep 1;192(5):709-12. Epub 2005 Jul 27. No abstract available.

PMID:
16088819

Supplemental Content

Support Center